government-protected monopolies

High prescription drug prices are attributable to several causes, including the approach the U.S. has taken to granting government-protected monopolies to drug manufacturers, and the restriction of price negotiation at a level not observed in other industrialized nations, according to a study appearing in the August 23/30 issue of JAMA. The increasing cost of prescription drugs in the United States has become a source of growing concern for patients, prescribers, payers, and policy makers...

Read More »